Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004914 · ClinicalTrials.gov registry record · Phase 2
Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00004914: Completed Phase 2 study, sponsored by Northwestern University.
NCT00004914 is a Phase 2 study that has completed, run by Northwestern University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004914, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Exercise may decrease anemia-related fatigue, improve strength, and build up lost muscle tissue. Epoetin alfa may help improve cancer-related anemia, energy levels, and quality of life. Exercise plus epoetin alfa may be effective treatment for anemia-related fatigue. PURPOSE: Phase II trial to study the effectiveness of exercise plus epoetin alfa in treating cancer patients who have anemia-related fatigue.
Interventions
- BIOLOGICAL epoetin alfa
- PROCEDURE physical therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-01 |
| Est. Completion | 2001-12 |
| Phase | Phase 2 |
What the finished NCT00004914 record still lists
NCT00004914 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which epoetin alfa is the first listed.
NCT00004914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004914 about?
NCT00004914 is a clinical study titled "Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue". RATIONALE: Exercise may decrease anemia-related fatigue, improve strength, and build up lost muscle tissue. Epoetin alfa may help improve cancer-related anemia, energy levels, and quality of life. Exercise plus epoetin alfa may be effective treatment for anemia-related fatigue. PURPOSE: Phase II tr...
What is the current status of trial NCT00004914?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-01. Estimated completion is 2001-12.
What interventions are being tested in trial NCT00004914?
The interventions under investigation include: epoetin alfa (BIOLOGICAL), physical therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00004914?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia